Abstract
Objectives
There are only a few detailed reports concerning the prognosticators following surgical resection of pulmonary metastases (PMs) from renal cell carcinoma (RCC). We investigated the prognosis of patients with RCC PMs undergoing pulmonary metastasectomy and identified prognostic factors in a multi-institutional retrospective study.
Methods
We retrospectively evaluated 84 patients who underwent resection of PMs from RCC between 1993 and 2014. We assessed the clinicopathological characteristics, focusing on the histological findings of PMs. We classified the histology into three types: pure clear cell carcinoma (N = 68), clear cell carcinoma combined with other histology type (N = 8), and non-clear cell carcinoma (N = 8). We examined the relationship between these histological types and the prognosis of patients with PMs from RCC.
Results
Complete resection was achieved in 78 patients (93%). The 5-year overall survival rate after metastasectomy was 59.7%. In multivariate analysis, three factors were found to be independent favorable prognostic factors of overall survival after lung metastasectomy [tumor size <2 cm, hazard ratio (HR) = 0.31, 95% confidence interval (CI) 0.13–0.78, P = 0.012; clear cell type, HR = 0.37, 95% CI 0.16–0.83, P = 0.025; and complete resection, HR = 0.27, 95% CI 0.10–0.78, P = 0.015].
Conclusions
This study indicates that a histological finding of the clear cell type is a significant favorable prognostic factor in addition to complete resection and a tumor size <2 cm. Histological evaluation of PM lesions is important for predicting survival after metastasectomy.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- DFI:
-
Disease-free interval
- HR:
-
Hazard ratio
- ND:
-
Nodal dissection
- OS:
-
Overall survival
- PM:
-
Pulmonary metastasis
- RCC:
-
Renal cell carcinoma
- RFS:
-
Recurrence-free survival
References
Motzer RJ, Bander NH (1996) Nanus DM renal-cell carcinoma. N Engl J Med 335:865–875
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
Marumo K, Kanayama H, Miyao N et al (2007) Prevalence of renal cell carcinoma: a nation-wide survey in Japan 2002. Int J Urol Off J Jpn Urol Assoc 14:479–482
Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166(1611–162):3
Piltz S, Meimarakis G, Wichmann MW et al (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(1082–108):7
Pfannschmidt J, Hoffmann H, Muley T et al (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74:1653–1657
Hofmann HS, Neef H, Krohe K et al (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48:77–81 (discussion 81–72)
Murthy SC, Kim K, Rice TW et al (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79:996–1003
Kawashima A, Nakayama M, Oka D et al (2011) Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience. Int J Clin Oncol 16:660–665
Kanzaki R, Higashiyama M, Fujiwara A et al (2011) Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardio Thorac Surg Off J Eur Assoc Cardio Thorac Surg 39:167–172
Meimarakis G, Angele M, Staehler M et al (2011) Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am J Surg 202:158–167
Assouad J, Petkova B, Berna P et al (2007) Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors. Ann Thorac Surg 84:1114–1120
Kudelin N, Bolukbas S, Eberlein M et al (2013) Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience. Ann Thorac Surg 96:265–270 (discussion 270–261)
Leibovich BC, Cheville JC, Lohse CM et al (2005) A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174:1759–1763 (discussion 1763)
Gudbjartsson T, Hardarson S, Petursdottir V et al (2005) Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48:593–600
Renaud S, Falcoz PE, Olland A et al (2013) Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? Interact CardioVasc Thorac Surg 16:525–528
Wang HY, Mills SE (2005) KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am J Surg Pathol 29:640–646
Yang XJ, Takahashi M, Schafernak KT et al (2007) Does ‘granular cell’ renal cell carcinoma exist? Mol Histol Reclassif Histopathol 50:678–680
Acknowledgements
The authors thank Dr. Jun Atsumi, Dr. Misaki Iijima, Dr. Yoko Azuma, Dr. Toshiki Yajima, and Ms. Kaori Takeshita for their support in data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors participated in this study and have agreed on the content of this paper. None has any financial or other relationship that could lead to a conflict of interest. The research was approved by the Institutional Review Board.
Additional information
The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see: http://www.textcheck.com/certificate/06CPsS.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig. 1
Overall survival (OS) and recurrence-free survival (RFS) curve after complete resection of 77 patients is shown. The 5-year OS rate after metastasectomy was 62.3% (A), and the 5-year RFS rate was 45.7% (B) (TIFF 63 kb)
Rights and permissions
About this article
Cite this article
Ohtaki, Y., Shimizu, K., Aokage, K. et al. Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma. World J Surg 41, 771–779 (2017). https://doi.org/10.1007/s00268-016-3802-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-016-3802-9